Bupropion Hydrochloride
- Product NDC
- 50268-141
- 11-digit product format
- 502680141
- Labeler code
- 50268
- Product ID
- 50268-141_d5ce8ebd-372c-3da7-e053-2a95a90a0997
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA077284
- Marketing category
- ANDA
- Marketing start
- 2016-10-14
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-141-15 | 50268014115 | 50 BLISTER PACK in 1 BOX (50268-141-15) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (50268-141-11) | 50 blister pack | 2016-10-14 | 0000-00-00 | No | No | Current |